Search Results

There are 12862 results for: content related to: Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010)

  1. Amiodarone: Pharmacology, Clinical Actions, and Relationships Between Them

    Journal of Cardiovascular Electrophysiology

    Volume 3, Issue 3, June 1992, Pages: 266–280, STANLEY NATTEL, MARIO TALAJIC, BERNARD FERMINI and DENIS ROY

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1540-8167.1992.tb00972.x

  2. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death

    Intervention Review

    The Cochrane Library

    Juan Carlos Claro, Roberto Candia, Gabriel Rada, Fernando Baraona, Francisco Larrondo and Luz M Letelier

    Published Online : 8 DEC 2015, DOI: 10.1002/14651858.CD008093.pub2

  3. Amiodarone: Pharmacology and Antiarrhythmic and Adverse Effects

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 5, Issue 6, November-December 1985, Pages: 298–311, Gerald V. Naccarelli, Robert L. Rinkenberger, Anne H. Dougherty and Ruth A. Giebel

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1985.tb03434.x

  4. Dual effects of amiodarone on pacemaker currents in hypertrophied ventricular myocytes isolated from spontaneously hypertensive rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 9, September 2014, Pages: 698–707, Hongxia Li, Yafeng Zhou, Bin Jiang, Xin Zhao, Xun Li, Xiangjun Yang and Wenping Jiang

    Version of Record online : 26 OCT 2014, DOI: 10.1111/1440-1681.12264

  5. You have free access to this content
    Amiodarone induces a caffeine-inhibited, MID1-depedent rise in free cytoplasmic calcium in Saccharomyces cerevisiae

    Molecular Microbiology

    Volume 47, Issue 1, January 2003, Pages: 223–234, William E. Courchesne and Sedide Ozturk

    Version of Record online : 18 DEC 2002, DOI: 10.1046/j.1365-2958.2003.03291.x

  6. Adverse Effects of Amiodarone

    Pacing and Clinical Electrophysiology

    Volume 21, Issue 1, January 1998, Pages: 108–120, MAHTAB JAFARI-FESHARAKI and MELVIN M. SCHEINMAN

    Version of Record online : 30 JUN 2006, DOI: 10.1111/j.1540-8159.1998.tb01068.x

  7. The Role of Free Radicals in the Pathogenesis of Amiodarone Toxicity

    Journal of Cardiovascular Electrophysiology

    Volume 4, Issue 2, April 1993, Pages: 161–177, ANDRAS VERECKEI, ANNA BLAZOVICS, ISTVAN GYORGY, ERZSEBET FEHER, MIKLOS TOTH, GABOR SZENASK, AGNES ZSINKA, GABOR FOLDIAK and JANOS FEHER

    Version of Record online : 29 APR 2007, DOI: 10.1111/j.1540-8167.1993.tb01220.x

  8. A Pharmacokinetic Study of the Combined Administration of Amiodarone and Ximelagatran, an Oral Direct Thrombin Inhibitor

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 1063–1071, Dr. Renli Teng, Dr. Troy C. Sarich, Dr. Ulf G. Eriksson, Ms. Jennifer E. Hamer, Mr. Stephen Gillette, Dr. Kajs-Marie Schützer, Dr. Glenn F. Carlson Jr and Dr. Peter R. Kowey

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268446

  9. Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 4, April 2009, Pages: 407–415, Dr Daniel J. Cushing, Dr Michael P. Adams, Dr Warren D. Cooper, Dr Peter R. Kowey and Dr Raymond J. Lipicky

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008330156

  10. You have free access to this content
    Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions

    British Journal of Clinical Pharmacology

    Volume 49, Issue 3, March 2000, Pages: 244–253, K. Ohyama , M. Nakajima , M. Suzuki , N. Shimada , H. Yamazaki and T. Yokoi

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00134.x

  11. A Review of Class III Antiarrhythmic Agents for Atrial Fibrillation: Maintenance of Normal Sinus Rhythm

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 12, December 2001, Pages: 1514–1529, James P. Tsikouris and Craig D. Cox

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.20.1514.34484

  12. Effects of Chronic Amiodarone on the Electrical Restitution in the Human Ventricle With Reference to Its Antiarrhythmic Efficacy

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 6, June 2011, Pages: 669–676, TOSHIYUKI OSAKA, ERIKO YOKOYAMA, HIDEYUKI HASEBE and ITSUO KODAMA

    Version of Record online : 15 JAN 2011, DOI: 10.1111/j.1540-8167.2010.01990.x

  13. Combined Amiodarone and Silymarin Treatment, But Not Amiodarone Alone, Prevents Sustained Atrial Flutter in Dogs

    Journal of Cardiovascular Electrophysiology

    Volume 14, Issue 8, August 2003, Pages: 861–867, András Vereckei, Henry R. Besch Jr. and Douglas P. Zipes

    Version of Record online : 22 JUL 2003, DOI: 10.1046/j.1540-8167.2003.02446.x

  14. Causality assessment of liver injury after chronic oral amiodarone intake

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 4, April 2009, Pages: 291–300, Lucía Llanos, Rocío Moreu, Ana M Peiró, Sonia Pascual, Rubén Francés, José Such, José F. Horga, Miguel Pérez-Mateo and Pedro Zapater

    Version of Record online : 22 JAN 2009, DOI: 10.1002/pds.1709

  15. Conversion of Recent-Onset Atrial Fibrillation with Intravenous Amiodarone: A Meta-Analysis of Randomized Controlled Trials

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 1, January 2002, Pages: 66–74, Dr. Daniel E. Hilleman and Dr. Sarah A. Spinler

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.1.66.33492

  16. A Short-Term, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

    Journal of Cardiovascular Electrophysiology

    Volume 21, Issue 6, June 2010, Pages: 597–605, JEAN-YVES LE HEUZEY, GAETANO M. DE FERRARI, DAVID RADZIK, MASSIMO SANTINI, JUNREN ZHU and JEAN-MARC DAVY

    Version of Record online : 6 APR 2010, DOI: 10.1111/j.1540-8167.2010.01764.x

  17. You have free access to this content
    Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity

    British Journal of Clinical Pharmacology

    Volume 67, Issue 5, May 2009, Pages: 511–519, Carmelo Lafuente-Lafuente, Jean-Claude Alvarez, Antoine Leenhardt, Stéphane Mouly, Fabrice Extramiana, Charles Caulin, Christian Funck-Brentano and Jean-François Bergmann

    Version of Record online : 2 FEB 2009, DOI: 10.1111/j.1365-2125.2009.03381.x

  18. You have free access to this content
    Effects of Dronedarone Started Rapidly After Amiodarone Discontinuation

    Clinical Cardiology

    Volume 36, Issue 2, February 2013, Pages: 88–95, Laura Immordino, Stuart Connolly, Harry Crijns, Denis Roy, Alessandro Capucci, David Radzik, Etienne Aliot, Stefan Hohnloser and Peter Kowey

    Version of Record online : 21 JAN 2013, DOI: 10.1002/clc.22090

  19. Population pharmacokinetics of long-term oral amiodarone therapy

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 6, June 2000, Pages: 642–652, P. Timothy Pollak, Thomas Bouillon and Steven L. Shafer

    Version of Record online : 15 JUN 2000, DOI: 10.1067/mcp.2000.107047

  20. Part IV: Class II, Class III, and Class IV Antiarrhythmic Drugs, Comparative Efficacy of Drugs, and Effect of Drugs on Mortality — A Review of Their Pharmaco kinetics, Efficacy, and Toxicity

    Journal of Cardiovascular Electrophysiology

    Volume 2, Issue 1, February 1991, Pages: 55–87, DAVID M. SALERNO

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1540-8167.1991.tb01714.x